Mount Sinai's Blood Test to Detect Antibodies to COVID-19 Receives Emergency Use Authorization From U.S. Food and Drug Administration - BroadcastMed
Maturity Models: CIO's Guide to a Successful Enterprise Imaging Strategy - Blog | Philips
Carlos Cordón-Cardo | Sociedad | EL PAÍS
The non-compliant patient, reconsidered | Philips
Medical Technology Blog
Carlos Cordón-Cardó | Sociedad | EL PAÍS
About Dr. Cordon-Cardo | Carlos Cordon-Cardo, MD, PhD
Mount Sinai applies algorithms, AI to classify disease | Fierce Healthcare
Mount Sinai Health System on Twitter: "Testing early for viral load may lead to better care for #patients with #COVID19. This study was led by Carlos Cordon-Cardo, MD, PhD: https://t.co/4VfUfsaOiJ #MountSinaiNews https://t.co/QMm5GwemUN" /
Events - Englander Institute for Precision Medicine
Maturity Models: CIO's Guide to a Successful Enterprise Imaging Strategy - Blog | Philips
Health Technology Explained | Philips
Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic
Carlos Cordon-Cardo, MD, PhD - Physician's Channel - Mount Sinai New York
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
COVID-19: Developing the Mount Sinai Antibody Test - Physician's Channel - Mount Sinai New York
Carlos Cordon-Cardo, MD, PhD - Physician's Channel - Mount Sinai New York
Carlos Cordon-Cardo | Icahn School of Medicine
Patient-centered care and technology: a powerful partnership | Philips
Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic
Mount Sinai Health System on Twitter: "Dr. Carlos Cordon-Cardo, Chair of the Department of Pathology at @MountSinaiNYC, will be speaking at the #AtlanticPulse Summit on Wednesday, July 15. RSVP to attend @AtlanticLIVE's
MountSinai Pathology (@MountSinai_Path) / Twitter
Carlos Cordon-Cardo - Wikipedia
